Advertisement

From the Journal

Case in Point
Case in Point
04/18/2024

James Matera, MD

James Matera, MD
A 24-year-old woman presented to the emergency department (ED) with joint swelling, severe arthralgias, and myalgias. She works as a nurse in a busy ED. She was admitted to the hospital for further workup. ...
04/18/2024
Case In Point
Case In Point
10/01/2021
A 47-year-old woman with a history of systemic lupus erythematosus presented for neurologic evaluation due to diplopia and ptosis that she had noted upon awakening 2 days earlier.
10/01/2021
Case In Point
Case In Point
07/21/2020
A 29-day-old girl was referred to a dermatology practice by a general pediatrics clinic after having been evaluated in the emergency department for a scattered erythematous eruption on her scalp, face,...
07/21/2020
DermClinic
DermClinic
12/04/2018

David L. Kaplan, MD—Series Editor

David L. Kaplan, MD—Series Editor
This 50-year-old woman presented for evaluation of asymptomatic but persistent discoloration on her arms of 2 months’ duration.
12/04/2018
Women's Health
Women's Health
07/27/2018
Lupus can lead to an unsafe pregnancy and must be monitored and managed at all stages. Megan Clowse, MD, from Duke University, answers our questions about challenges that come with lupus in women who are...
07/27/2018
Lupus
Lupus
12/21/2015

Timothy H. Self, PharmD, and Ryan E. Owens, PharmD, BCPS

Timothy H. Self, PharmD, and Ryan E. Owens, PharmD, BCPS
Hydralazine was introduced as an antihypertensive agent in the early 1950s and was quickly found to induce systemic lupus erythematosus (SLE).
12/21/2015